vs
Forward Industries, Inc.（FWDI）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Forward Industries, Inc.的1.7倍（$35.5M vs $21.4M），RECURSION PHARMACEUTICALS, INC.净利率更高（-304.2% vs -2732.2%，领先2427.9%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 224.0%），过去两年Forward Industries, Inc.的营收复合增速更高（74.6% vs 60.5%）
梅尔罗斯工业公众有限公司是一家总部位于英格兰伯明翰的英国航空航天制造企业，是吉凯恩航空航天的母公司，公司股票在伦敦证券交易所上市，同时是富时100指数的成分股。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
FWDI vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.7倍
$21.4M
营收增速更快
RXRX
高出457.7%
224.0%
净利率更高
RXRX
高出2427.9%
-2732.2%
两年增速更快
FWDI
近两年复合增速
60.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $21.4M | $35.5M |
| 净利润 | $-585.7M | $-108.1M |
| 毛利率 | 78.6% | 59.8% |
| 营业利润率 | -2722.8% | -304.8% |
| 净利率 | -2732.2% | -304.2% |
| 营收同比 | 224.0% | 681.7% |
| 净利润同比 | -82611.5% | 39.6% |
| 每股收益（稀释后） | $-5.91 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FWDIRXRX
| Q4 25 | $21.4M | $35.5M | ||
| Q3 25 | $7.9M | $5.2M | ||
| Q2 25 | $2.5M | $19.2M | ||
| Q1 25 | $3.1M | $14.7M | ||
| Q4 24 | $6.6M | $4.5M | ||
| Q3 24 | — | $26.1M | ||
| Q2 24 | $7.8M | $14.4M | ||
| Q1 24 | $5.1M | $13.8M |
净利润FWDIRXRX
| Q4 25 | $-585.7M | $-108.1M | ||
| Q3 25 | $-164.0M | $-162.3M | ||
| Q2 25 | $-850.0K | $-171.9M | ||
| Q1 25 | $-1.5M | $-202.5M | ||
| Q4 24 | $-708.1K | $-178.9M | ||
| Q3 24 | — | $-95.8M | ||
| Q2 24 | $-399.6K | $-97.5M | ||
| Q1 24 | $-553.2K | $-91.4M |
毛利率FWDIRXRX
| Q4 25 | 78.6% | 59.8% | ||
| Q3 25 | 61.1% | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | -5.7% | -48.0% | ||
| Q4 24 | 17.1% | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | 16.8% | 36.2% | ||
| Q1 24 | 26.2% | 19.1% |
营业利润率FWDIRXRX
| Q4 25 | -2722.8% | -304.8% | ||
| Q3 25 | -39.2% | -3327.6% | ||
| Q2 25 | -102.6% | -916.8% | ||
| Q1 25 | -58.3% | -1297.9% | ||
| Q4 24 | -13.6% | -4042.4% | ||
| Q3 24 | — | -377.1% | ||
| Q2 24 | -5.9% | -697.4% | ||
| Q1 24 | -12.2% | -698.4% |
净利率FWDIRXRX
| Q4 25 | -2732.2% | -304.2% | ||
| Q3 25 | -2063.6% | -3135.3% | ||
| Q2 25 | -34.1% | -894.2% | ||
| Q1 25 | -46.5% | -1373.3% | ||
| Q4 24 | -10.7% | -3935.5% | ||
| Q3 24 | — | -367.5% | ||
| Q2 24 | -5.1% | -676.6% | ||
| Q1 24 | -10.9% | -662.4% |
每股收益（稀释后）FWDIRXRX
| Q4 25 | $-5.91 | $-0.17 | ||
| Q3 25 | $-21.86 | $-0.36 | ||
| Q2 25 | $-0.77 | $-0.41 | ||
| Q1 25 | $-1.32 | $-0.50 | ||
| Q4 24 | $-0.64 | $-0.56 | ||
| Q3 24 | — | $-0.34 | ||
| Q2 24 | $-0.36 | $-0.40 | ||
| Q1 24 | $-0.50 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $880.9M | $1.1B |
| 总资产 | $892.9M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资FWDIRXRX
| Q4 25 | — | $743.3M | ||
| Q3 25 | — | $659.8M | ||
| Q2 25 | — | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | — | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
总债务FWDIRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益FWDIRXRX
| Q4 25 | $880.9M | $1.1B | ||
| Q3 25 | $1.5B | $1.0B | ||
| Q2 25 | $3.4M | $919.1M | ||
| Q1 25 | $3.6M | $933.9M | ||
| Q4 24 | $2.3M | $1.0B | ||
| Q3 24 | — | $524.6M | ||
| Q2 24 | $1.4M | $584.4M | ||
| Q1 24 | $1.8M | $401.2M |
总资产FWDIRXRX
| Q4 25 | $892.9M | $1.5B | ||
| Q3 25 | $1.5B | $1.4B | ||
| Q2 25 | $8.3M | $1.3B | ||
| Q1 25 | $12.3M | $1.3B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $726.5M | ||
| Q2 24 | $15.2M | $775.9M | ||
| Q1 24 | $15.2M | $557.8M |
负债/权益比FWDIRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-7.9M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | 0.0% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
经营现金流FWDIRXRX
| Q4 25 | $-7.9M | $-46.1M | ||
| Q3 25 | $-4.5M | $-117.4M | ||
| Q2 25 | $-1.2M | $-76.4M | ||
| Q1 25 | $-537.6K | $-132.0M | ||
| Q4 24 | $-434.3K | $-115.4M | ||
| Q3 24 | — | $-59.2M | ||
| Q2 24 | $436.0K | $-82.2M | ||
| Q1 24 | — | $-102.3M |
自由现金流FWDIRXRX
| Q4 25 | — | $-47.3M | ||
| Q3 25 | $-4.5M | $-117.6M | ||
| Q2 25 | $-1.2M | $-79.6M | ||
| Q1 25 | $-539.0K | $-133.8M | ||
| Q4 24 | $-439.7K | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | $426.8K | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率FWDIRXRX
| Q4 25 | — | -133.1% | ||
| Q3 25 | -57.0% | -2272.5% | ||
| Q2 25 | -50.0% | -413.9% | ||
| Q1 25 | -17.3% | -907.4% | ||
| Q4 24 | -6.6% | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | 5.5% | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度FWDIRXRX
| Q4 25 | 0.0% | 3.5% | ||
| Q3 25 | 0.3% | 4.7% | ||
| Q2 25 | 0.8% | 16.4% | ||
| Q1 25 | 0.0% | 12.4% | ||
| Q4 24 | 0.1% | 28.6% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | 0.1% | 8.2% | ||
| Q1 24 | — | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FWDI
| CODM | $17.4M | 81% |
| Design Segment | $4.1M | 19% |
RXRX
暂无分部数据
